The Cannigma

FEBRUARY 1, 2023

Before we dive into the research, here’s the lowdown: Important takeaway points on cannabis and cancer Your situation is unique. Advocate for the rescheduling of cannabis to improve access to cannabis for research purposes, and scientific funding for novel cannabinoid-based cancer therapies. 1 So can cannabis cure cancer?

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.

Research and Development 112

Research and Development Data THC Clinical Trials 112

Medicinal Marijuana Association

FEBRUARY 10, 2024

With over 100 known cannabinoids in cannabis, staying informed about the latest research is crucial for making informed decisions. Understanding how to discern reliable sources, interpret research methodologies, and apply key findings to real-world scenarios can be daunting.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

Cannabis Law Report

AUGUST 1, 2021

Unfortunately, on the negative side, Connecticut yet again extended the 10% surcharge on the corporation business tax, and delayed and extended the phase-out of the capital base tax on corporations.

Research and Development 105

Research and Development Programs Legislation Business 105

NewsMunchies

JULY 10, 2023

Artificial intelligence is a smarter, faster, and more effective pathway to drug development. With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds major potential to increase the accessibility of drugs and to treat diseases and conditions.

Treatment 58

Treatment Research and Development Pharmaceutical Microdosing 58

Veriheal

JUNE 22, 2020

Whether or not cannabis use during pregnancy causes physical, cognitive, or mental impairments later in life has been something scientists and researchers have been investigating for decades. Unfortunately, much of the research conducted thus far have not shown the whole picture or clinical implications for children in real life.

Research and Development 98

Research and Development Data Policy Education 98

Cannabis Law Report

APRIL 28, 2021

Poster presentation to address the preclinical cannabidiol derivative for the potential treatment of psychiatric disorders BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq:… Read More.

Pharmaceutical 98

Pharmaceutical Data Medicine Treatment 98

Veriheal

NOVEMBER 30, 2021

Veriheal does not support illegally consuming therapeutic substances such as psilocybin but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies.

Research and Development 98

Research and Development Therapy Data Treatment 98

Veriheal

SEPTEMBER 14, 2021

The findings of a new study into cannabis use disorder (CUD) among veterans have been released by a team of researchers from Pennsylvania’s Center of Excellence in Substance Addiction Treatment and Education at the Corporal Michael J. Crescenz VA Medical Center. Their hypothesis was published in the American Journal of Psychiatry.

Consumption 98

Consumption Research and Development Treatment Programs 98

Cannabis Law Report

JUNE 4, 2021

Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. The post AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591 appeared first on CannabisFN. Phase 2 trial underway.

Data 100

Data Research and Development Clinical Trials Therapy 100

The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. So Releaf app is an app that we released back in 2016.

Data 104

Data Research and Development Patients Strains 104

Cannabis Law Report

JULY 8, 2021

(NYSE American: YCBD, YCBDpA), one of the leading, and most highly trusted and recognized CBD companies, announced today that its recently formed division, cbdMD Therapeutics, has initiated talks with one of the leading US cannabinoid research institutes, to identify novel cannabinoids for therapeutic use. About cbdMD, Inc. cbdMD, Inc.

Research and Development 111

Research and Development Pets Cannabinoids eCommerce 111

Veriheal

JANUARY 31, 2023

Researchers Reach a Moral Conundrum According to Vikiana Clement, the former executive director of the Cannabis Education Task Force at Brooklyn’s Medgar Evers College and the researcher, purchasing cannabis from the illicit market may be the “true moral choice” depending on circumstances. This is a data analysis.”

Legalization 104

Legalization Research and Development Business Cannabis 104

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Cannabis Law Report

DECEMBER 27, 2019

Clinical trials are medical research projects involving human participants. However, the costs of conducting a full-scale clinical trial can be prohibitive, posing barriers to research for cannabis companies. Cognizance VCT enables the generation of cost-effective quality data with ethical consent, on par with academic studies.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Cannabis Law Report

FEBRUARY 10, 2022

~Gary Allen, CEO, New Frontier Data. Our latest report, 22 for 2022: Cannabis Industry Assertions & Predictions, provides a data-centric blueprint for navigating near-term challenges and positioning for new opportunities in a burgeoning industry.

Data 52

Data Research and Development Hemp Legalization 52

Cannabis Law Report

JULY 28, 2021

The study was conducted by a respected contract research organization with deep expertise in preclinical oncology model development and drug testing and data corresponding to all studied cancer cell lines have now been reported to the Company. . – July 28, 2021) – PharmaDrug Inc.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Veriheal

FEBRUARY 19, 2021

The lack of research is one of the many reasons that cannabis remains federally illegal. But one of the barriers to conducting the necessary research is its federally illegal status. These intertwining factors plaguing cannabis research must be eradicated for the sake of medical cannabis consumers. .

Legalization 94

Legalization Research and Development Safety Data 94

Cannabis Law Report

JULY 7, 2021

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. MYMD-1 is being developed to treat autoimmune and age-related diseases, and to slow aging thereby increasing life-span. Acumen Research and Consulting confirmed TNF-? President, Director and Chief Medical Officer of MyMD.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

Cannabis Law Report

JANUARY 7, 2022

Our NXTecK™ platform is introducing scalable, aggregated, and normalized consumer data with an attribution model, so you know exactly where and how to focus your multi-channel strategies and achieve your digital marketing goals. Free Access to Equio ®. Sponsorship and Marketing Offerings.

Data 52

Data Research and Development Access Retail 52

SpeedWeed

APRIL 2, 2021

Some of these claims were based on outdated research, but scientists are now discovering that alcohol , not weed, is responsible for these developmental issues. A new study published in the Biological Psychiatry journal is adding to the growing evidence that alcohol impairs adolescent brain development in ways that weed does not.

Research and Development 52

Research and Development History Media Collective 52

SpeedWeed

MAY 18, 2021

Drug Enforcement Administration (DEA) quietly made an announcement that’s expected to have a profound and long-lasting impact on cannabis research and development in the United States. cannabis researchers. For years, NIDA and the DEA have promised to open up the sourcing of federally-approved research cannabis.

DEA 52

DEA Research and Development Data Cannabis 52

Cannabis Law Report

OCTOBER 10, 2019

Zefyr Inc , a data analytics firm described in a news announcement as the “Nielsen” of cannabis. Cannabis Big Data Firm to Acquire Zefyr, the ‘Alexa’ of Cannabis. New Frontier Data to Launch Joint Marketing Tech Offering for Mature Market Entrants. Here’s the PR. October 9, 2019.

Data 40

Data Research and Development Business Policy 40

Cannabis Law Report

JULY 29, 2021

Scientists and researchers do not know exactly how or why these negative results occur, but they are still working on the question. Our main product is the Ehave Telemetry Portal, which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insights. Gabe@Ehave.com.

Research and Development 105

Research and Development Conditions Data Patients 105

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. billion by 2027.

Therapy 76

Therapy Data Research and Development Events 76

Cannabis Law Report

NOVEMBER 2, 2021

Earlier this month, the FDA released a seven-page plan to accelerate its research into the safety of cannabis-derived products. This emphasis on obtaining more information suggests the FDA is some time away from developing a robust, national CBD enforcement strategy. 01 November 2021. Perkins Coie LLP.

Safety 52

Safety Data Supply Chain Research and Development 52

SpeedWeed

JULY 7, 2021

However, it could take several years to build out those facilities, become GMP-certified and -compliant—which the Mexican government requires for the entire supply chain—gather stability data and so on, Detwiler said. View original article.

Research and Development 52

Research and Development Pharmaceutical Cannabinoids Supply Chain 52

Veriheal

NOVEMBER 13, 2020

Until recently, there has been little to no research available that examines the effects of cannabis in patients diagnosed with Obsessive-Compulsive Disorder (OCD). Thanks to an ever increasing interest in the medical benefits of cannabis, a study was recently conducted that researched the acute effects of cannabis on the symptoms of OCD.

Research and Development 98

Research and Development Consumption Patients Strains 98

The Joint Blog

JULY 25, 2024

This article explores recent research on cannabis and mental health, examining both the benefits and risks associated with its use. Long-term or heavy use of THC has been linked to an increased risk of developing psychiatric disorders such as psychosis and schizophrenia.

Research and Development 26

Research and Development THC CBD Cannabis 26

Cannabis Law Report

JANUARY 19, 2022

Aligning with the leading market data industry trends in analytical financial services, DeFi, and Index Management allowed the firm to boost its revenue by 45% during 2021, continuing the trend of annual double-digit growth totaling over 560% since 2016. We plan to continue developing our analytical services line. About dxFeed.

Data 52

Data Research and Development Retail Business 52

SpeedWeed

JULY 12, 2021

Researchers have developed a new experimental compound that may be able to provide the stress-relieving properties of ibogaine without the toxic or hallucinogenic side effects. . Amazingly, TBG reversed all of the effects of stress… I had a hard time believing it even when I saw the initial data.”.

Research and Development 52

Research and Development Data Medicine Treatment 52

Cannabis Law Report

APRIL 19, 2019

A female CEO of a cannabis research company is fighting back against controversial Marijuana investor Andy Defrancesco after he started a twitter campaign to allegedly disparage her company and her personal ethics as a CEO. Read on at … Sol Global Chairman Andy Defrancesco sued for Defamation by Cannabis Research Firm: $SOLCF.

Research and Development 61

Research and Development Data Media Banking 61

Cannabis Law Report

AUGUST 30, 2021

.–(BUSINESS WIRE)– #cannabis — Dewey Scientific , an agtech innovator pioneering solutions for a sustainable and thriving cannabis industry, announced today the online publication of new data describing the first experimentally validated disease resistance gene in cannabis. Garfinkel, PhD.

Research and Development 103

Research and Development Sativa Agriculture Cultivation 103

Cannabis Law Report

AUGUST 9, 2022

August 08, 2022 09:30 ET | Source: Allied Market Research. 08, 2022 (GLOBE NEWSWIRE) — According to the report published by Allied Market Research, the global hemp clothing market generated $2.29 … portland, OR, Aug. billion in 2021, and is projected to reach $23.02 billion by 2031, growing at a CAGR of 27.1%

Hemp 52

Hemp Research and Development Data Business 52

Cannabis Law Report

SEPTEMBER 23, 2021

This data will assist Awakn’s progress by enabling a better design and more efficient execution of its clinical program. Awakn will now be able to accelerate its clinical research into a phase IIb randomized controlled trial (RCT) in the U.K. . – September 23, 2021) – Awakn Life Sciences Corp., (NEO:

Research and Development 52

Research and Development Therapy Treatment Data 52

Cannabis Law Report

APRIL 28, 2022

Get a bunch of researchers to research it, publish a report for committees to mull over and then ignore. The researchers leading the study were all affiliated with The University of Queensland , and they examined, “historical changes in legalization attitudes and the period-specific individual and external influences on these.”. “A

Legalization 52

Legalization Research and Development Media Data 52